- Home
- TLSA vs VSTM Comparison
TLSA vs VSTM Comparison
Compare TLSA & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- VSTM
- Stock Information
- Founded
- TLSA 2013
- VSTM 2010
- Country
- TLSA United Kingdom
- VSTM United States
- Employees
- TLSA N/A
- VSTM N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- TLSA Health Care
- VSTM Health Care
- Exchange
- TLSA Nasdaq
- VSTM Nasdaq
- Market Cap
- TLSA 187.0M
- VSTM 425.9M
- IPO Year
- TLSA 2000
- VSTM 2012
- Fundamental
- Price
- TLSA $1.45
- VSTM $4.69
- Analyst Decision
- TLSA
- VSTM Strong Buy
- Analyst Count
- TLSA 0
- VSTM 9
- Target Price
- TLSA N/A
- VSTM $12.63
- AVG Volume (30 Days)
- TLSA 246.7K
- VSTM 2.5M
- Earning Date
- TLSA 07-22-2025
- VSTM 08-07-2025
- Dividend Yield
- TLSA N/A
- VSTM N/A
- EPS Growth
- TLSA N/A
- VSTM N/A
- EPS
- TLSA N/A
- VSTM N/A
- Revenue
- TLSA N/A
- VSTM $10,000,000.00
- Revenue This Year
- TLSA N/A
- VSTM $129.06
- Revenue Next Year
- TLSA N/A
- VSTM $306.32
- P/E Ratio
- TLSA N/A
- VSTM N/A
- Revenue Growth
- TLSA N/A
- VSTM N/A
- 52 Week Low
- TLSA $0.63
- VSTM $2.10
- 52 Week High
- TLSA $1.91
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- TLSA 48.43
- VSTM 39.03
- Support Level
- TLSA $1.43
- VSTM $4.60
- Resistance Level
- TLSA $1.81
- VSTM $4.90
- Average True Range (ATR)
- TLSA 0.09
- VSTM 0.32
- MACD
- TLSA -0.02
- VSTM 0.10
- Stochastic Oscillator
- TLSA 18.53
- VSTM 64.29
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.